KM Pharmacy Co. Ltd. (225430) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for KM Pharmacy Co. Ltd. (225430:KRX), powered by AI.

Current Price
₩3,035
P/E Ratio
-4.3
Market Cap
16.9B
Sector
Financial Services
What is the KM Pharmacy Co. Ltd. stock price forecast?

KM Pharmacy Co. Ltd. is currently trading at ₩3,035. View real-time AI analysis on Alpha Lenz.

What is KM Pharmacy Co. Ltd. insider trading activity?

View the latest insider trading data for KM Pharmacy Co. Ltd. on Alpha Lenz.

What is KM Pharmacy Co. Ltd.'s P/E ratio?

KM Pharmacy Co. Ltd.'s P/E ratio is -4.3.

KM Pharmacy Co. Ltd.

KRX · 225430
₩3,035+700(+29.98%)Market closedKRX regular session 09:00–15:30 KST
Ask about KM Pharmacy Co. Ltd.'s future dividend policy...
Alpha Chat Insight

KM Pharmacy Co. Ltd. trades at a P/E of -4.3 (undervalued) with modest ROE of -13.0%.

Ask for details

Company Overview

KM Pharmacy Co. Ltd. is a prominent player in the pharmaceutical sector, primarily focused on the distribution and retail of pharmaceutical products. The company's main function is to provide an extensive range of medicinal goods and health-related products to consumers, ensuring accessibility and availability in the healthcare market. KM Pharmacy is recognized for its comprehensive network of pharmacies that cater to the needs of a diverse customer base, including individuals seeking prescription medicines, over-the-counter (OTC) drugs, as well as health and wellness products. This company plays a significant role in the healthcare supply chain, impacting sectors such as healthcare services, consumer health, and wellness industries. By ensuring timely delivery and stocking of essential drugs, KM Pharmacy contributes to the overall efficiency of healthcare services. With a business model centered around customer service and product reliability, KM Pharmacy Co. Ltd. is an integral part of the healthcare infrastructure, supporting patient care and pharmaceutical logistics. Its presence in the market is crucial for maintaining steady drug availability, thereby influencing the broader pharmaceutical and consumer health markets.

CEO강일모, 백승원(BAIK BRIAN SEUNG WON) (각자 대표)
SectorFinancial Services
IndustryAsset Management
0

Company Statistics

FY 2025

Profile

₩16,927,439,350Market Cap
₩15,989,987,100Revenue
5.58MShares Out
0Employees

Margins

24.00%Gross
-10.28%EBITDA
-18.28%Operating
-24.29%Pre-Tax
-24.82%Net

Valuation

-4.27P/E
0.60P/B
1.06EV/Sales
-19.69EV/EBITDA
-8.41P/FCF

Growth (CAGR)

0.76%Rev 3Yr
-6.95%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-8.32%ROA
-13.04%ROE
-6.90%ROIC

Financial Health

₩350,617,090Cash & Cash Equivalents
₩17,776,249,890Net Debt
64.13%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

KM Pharmacy Co. Ltd. (ticker: 225430) is a company listed on KRX in the Financial Services sector (Asset Management). Market cap is $16.9B.

The current price is ₩3,035 with a P/E ratio of -4.27x and P/B of 0.6x.

ROE is -13.04% and operating margin is -18.28%. Annual revenue is $16.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
KM Pharmacy Co. Ltd. (225430) Stock Forecast 2026 ₩3,035 — Price, Financials & Analyst Targets | Alpha Lenz